Bristol Myers Squibb-AstraZeneca EEIG

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH, UK
Telephone: +44(0)1895523010
Fax: +44(0)1895523010
E-mail: medical.information@bms.com
Medical Information Direct Line: +44(0)8007311736
Medical Information Fax: +44(0)1895523677


Patient Information Leaflet last updated on the eMC: 11/01/2012
PIL Onglyza 2.5mg & 5mg film-coated tablets

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. This PIL is in PDF format.

View Patient Information Leaflet (0.208MB)

Are you having problems printing this pdf? Please click here for help.

Can't read the PDF? Visit adobe.com and download the Adobe Acrobat Reader.


More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/22314/XPIL/


Black Triangle

This medicine is monitored intensively by the CHM and MHRA

Active Ingredients/Generics

 
   saxagliptin hydrochloride